1. Home
  2. Clinical Topics
  3. FDA approves new drug for irritable bowel syndrome and constipation
Clinical TopicsDrugs and DevicesGastroenterologyHealthcare & TechnologyNewsWeb Exclusives

FDA approves new drug for irritable bowel syndrome and constipation

Share

On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts